Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Imaging Narrowed Brain Arteries Before Stenting Treatment

Uses an imaging scan to study narrowed brain arteries in adults before stent treatment.

Plain-language title generated from the registry record
Registry title: Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis

Key facts

Where
Beijing, ChinaSee the site

Where in China

  • Xuanwu Hospital, Capital Medical UniversityBeijing, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
jiaoliqun
Trial code
NCT05550077
Record updated
23 September 2022
Original description
To evaluate the clinical significance of optical coherence tomography (OCT) in interventional treatment of intracranial atherosclerotic stenosis (ICAS).Read full original descriptionShow less

Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis: a Prospective Registry Study (OCT-ICAS)

To evaluate the clinical significance of optical coherence tomography (OCT) in interventional treatment of intracranial atherosclerotic stenosis (ICAS).

Inclusion: Symptomatic ICAS. Participants with ICAS with a transient ischaemic attack (TIA) or stroke attributable to the territory of the stenotic artery were defined as symptomatic. A TIA was defined as a transient episode of neurological dysfunction (focal weakness or language disturbance, transient monocular blindness, or required assistance in walking) caused by focal brain or retinal ischaemia that lasted for at least 10 minutes but resolved within 24 hours; Stenotic degree ≥ 50%, measured by digital subtraction angiography; The stenosis must located in at least one major intracranial artery (internal carotid artery, vertebral artery, middle cerebral artery, or basilar artery).

Exclusion: Arteriovenous Malformation; Aneurysm.

ClinicalTrials.gov NCT05550077